1.
|
Phase: Phase III
Type: Prevention
Status: Approved-not yet active
Age: 40 to 60
Sponsor: Other
Protocol IDs: CREAT, NCT01496521
|
|
2.
|
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792
|
|
4.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 64
Sponsor: Other
Protocol IDs: 0806M36121, NCT00917735
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 50 to 69
Sponsor: Other
Protocol IDs: UB-ProDiet, UB-ProDiet CRUK/07/057, CRUK-07/057, ISRCTN-95931417, EU-21031, NCT01105338
|
|
6.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320
|
|
7.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 40 and over
Sponsor: NCI
Protocol IDs: MAYO-MC084C, MC084C, R01-CA-132991
|
|
8.
|
Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 10-089, NCT01239095
|
|
9.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: GTESCLC2011, NCT01317953
|
Mobile | Español
